BSESanjivani Paranteral LtdMediumNeutral
Announced Thu, 11 Sept · 19:19 IST

Appointment of Non-executive Independent Director

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Sanjivani Paranteral Ltd has appointed Mr. Basant Shrivastava (DIN: 02645245) as a Non-Executive Independent Director with effect from 11th September 2025, for a term of 5 years, subject to shareholder approval at the next AGM. Mr. Shrivastava is 69 years old, holds an M.Sc. in Chemistry and an MBA from Jamnalal Bajaj Institute of Management Studies. He brings over 40 years of pharmaceutical industry experience, including senior sales roles at Johnson & Johnson and entrepreneurship through Vita Pharma Agencies and Vita Bio International Pvt. Ltd. He currently serves as Joint Director at Joint Force Pharma Ltd. The appointment was recommended by the Nomination and Remuneration Committee, and he is not related to any existing Director on the board.

Likely market impact

This is a routine board composition change that brings experienced pharmaceutical industry expertise to the company. It is unlikely to have an immediate material impact on the stock price, but strengthens independent oversight on the board.